Table 1: Compare the mean of NCV in treated patients with phenytoin by type of nerve.
Type of nerves |
Drugs |
Mean |
P - value |
Median
|
Phenytoin in Baseline |
52 |
0.009
|
Control |
58.7 |
||
Median
|
Phenytoin in baseline |
52 |
0.016
|
Phenytoin 6 month late |
51.6 |
||
Ulnar
|
Phenytoin in Baseline |
51.2 |
0.058
|
Control |
50.8 |
||
Ulnar
|
Phenytoin in baseline |
51.2 |
0.011
|
Phenytoin 6 month late |
50.6 |
||
Sural
|
Phenytoin in Baseline |
47.7 |
0.002
|
Control |
50.6 |
||
Sural
|
Phenytoin in baseline |
47.7 |
0.026
|
Phenytoin 6 month late |
47.2 |
||
Peroneal
|
Phenytoin in Baseline |
43.8 |
0.002
|
Control |
46.4 |
||
Peroneal |
Phenytoin in baseline |
43.8 |
0.009 |
Phenytoin 6 month late |
42.9 |